drugset / Trial / NCT03755596
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
Phase 4
Completed
184 enrolled
Fundação Educacional Serra dos Órgãos
Melora do Brasil Produtos Dermatológicos S/A · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, case control study of 180 patients presenting motion sickness, who will perform a motion sickness assessment questionnaire before and after treatment with dry ginger (Z. officinale) extract.
Timeline
- Start
- 2019-01-02
- Primary completion
- 2019-04-30
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginger | Traditional medicine (herbal / TCM) | 160 mg | Oral |